FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Holger Moch

Research Profile

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Neoplasm Staging

Phenomena

Nucleic Acid Hybridization

Physiology

Anatomy

Tumor Cell Line

Co-author Network

Publications

TOP 3
Daniela Lenggenhager; Ewerton M Maggio; Holger Moch; Matthias Rössle
HBME-1 expression in hyalinizing trabecular tumours of the thyroid gland.
Markus Rechsteiner; Jan H Rüschoff; Peter Schraml; Adriana von Teichman; Achim Weber; Peter Wild; Dieter Zimmermann; Niklaus Fankhauser; Bernhard Pestalozzi; Holger Moch
KRAS, BRAF, and TP53 Deep Sequencing for Colorectal Carcinoma Patient Diagnostics.
Anne-Katrin Zimmermann; Daniel Fink; Jochen Imig; Agnes Klar; Alexander Knuth; Dimitri Korol; Holger Moch; Christoph Renner; Gad Singer; Sylvia Stadlmann; Rosmarie Caduff
Expression of MAGE-C1/CT7 and selected cancer/testis antigens in ovarian borderline tumours and primary and recurrent ovarian carcinomas.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Holger Moch (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Daniela Lenggenhager; Ewerton M Maggio; Holger Moch; Matthias Rössle
HBME-1 expression in hyalinizing trabecular tumours of the thyroid gland.
Histopathology 2013;62(7):1092-7.
2013: Markus Rechsteiner; Jan H Rüschoff; Peter Schraml; Adriana von Teichman; Achim Weber; Peter Wild; Dieter Zimmermann; Niklaus Fankhauser; Bernhard Pestalozzi; Holger Moch
KRAS, BRAF, and TP53 Deep Sequencing for Colorectal Carcinoma Patient Diagnostics.
The Journal of molecular diagnostics : JMD 2013;15(3):299-311.
2013: Anne-Katrin Zimmermann; Daniel Fink; Jochen Imig; Agnes Klar; Alexander Knuth; Dimitri Korol; Holger Moch; Christoph Renner; Gad Singer; Sylvia Stadlmann; Rosmarie Caduff
Expression of MAGE-C1/CT7 and selected cancer/testis antigens in ovarian borderline tumours and primary and recurrent ovarian carcinomas.
Virchows Archiv : an international journal of pathology 2013;462(5):565-74.
2013: Silvia Casagrande; Wilhelm Krek; Sonja Brun-Schmid; Laura Morra; Markus Rechsteiner; Melanie Ruf; Peter Schraml; Adriana von Teichman; Holger Moch
The protein tyrosine phosphatase receptor type J is regulated by the pVHL-HIF axis in clear cell renal cell carcinoma.
The Journal of pathology 2013;229(4):525-34.
2013: Patrick Roth; Peter Schraml; Manuela Silginer; Ghazaleh Tabatabai; Svenja Thies; Isabel Tritschler; Simon L Goodman; Kathy Hasenbach; Gabriele Maurer; Holger Moch; Michael Weller
Integrin control of the transforming growth factor-β pathway in glioblastoma.
Brain : a journal of neurology 2013;136(Pt 2):564-76.
2013: Przemyslaw Blyszczuk; Urs Eriksson; Marcel Glönkler; Silvia Behnke; Corinne Berthonneche; Thomas F Lüscher; Holger Moch; Thierry Pedrazzini; Gabriela Kania
Nitric oxide synthase 2 is required for conversion of pro-fibrogenic inflammatory CD133(+) progenitors into F4/80(+) macrophages in experimental autoimmune myocarditis.
Cardiovascular research 2013;97(2):219-29.
2013: Holger Moch
An overview of renal cell cancer: pathology and genetics.
Seminars in cancer biology 2013;23(1):3-9.
2013: S Brandt; B Lohe; Holger Moch; T Rüdiger; A Vogetseder; P Bode
[Primitive neuroectodermal tumor of the testis. Molecular analysis and discussion of genesis].
Der Pathologe 2013;34(1):70-3.
2013: Rafal Pawłowski; Wilhelm Krek; Holger Moch; Sarah M Mühl; Tullio Sulser; Peter Schraml
Loss of PBRM1 expression is associated with renal cell carcinoma progression.
International journal of cancer. Journal international du cancer 2013;132(2):E11-7.
2013: Zsuzsanna Varga; Arthur von Hochstetter; Florian Fritzsche; Aurelia Noske; Peter Schraml; Peter Sinn; Christoph Tausch; Andreas Trojan; Holger Moch
Comparison of EndoPredict and Oncotype DX test results in hormone receptor positive invasive breast cancer.
PloS one 2013;8(3):e58483.
2013: Nina Zeh; Peter K Bode; Glen Kristiansen; Holger Moch; Tullio Sulser; Peter J Wild; Thomas Hermanns
Retroperitoneal teratoma with somatic malignant transformation: a papillary renal cell carcinoma in a testicular germ cell tumour metastasis following platinum-based chemotherapy.
BMC urology 2013;13():9.
2012: Marie-Angela Wulf; Dieter Zimmermann; Walter Weder; Beata Bode; Holger Moch; Kaspar Rufibach; Alex Soltermann; Verena Tischler
Silver-enhanced in situ hybridization for determination of EGFR copy number alterations in non-small cell lung cancer.
The American journal of surgical pathology 2012;36(12):1801-8.
2012: Holger Moch
[Renal cancer biomarkers. What is justified?].
Der Pathologe 2012;33 Suppl 2():278-81.
2012: Adriana von Teichman; Martina Storz; Susanne Dettwiler; Holger Moch; Peter Schraml
Whole genome and transcriptome amplification: practicable tools for sustainable tissue biobanking?
Virchows Archiv : an international journal of pathology 2012;461(5):571-80.
2012: Ruta Gupta; Donna E Hansel; Ondrej Hes; Wolfram Jochum; Holger Moch; Adeboye O Osunkoya; Paulo G Salles; Rajal B Shah; Mahesha Vankalakunti; Ming Zhou; Carlos E Bacchi; Athanase Billis; Rafael A Cabrera; Marilia G de Castro; Allen M Gown; Mahul B Amin
Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma: clinicopathologic analysis of 52 cases of rare aggressive subtypes of renal cell carcinoma with a focus on their interrelationship.
The American journal of surgical pathology 2012;36(9):1265-78.
2012: Olga Shakhova; Michael Wegner; Daniel Zingg; Yann Barrandon; Friedrich Beermann; Jacqueline Blunschi; Paolo Cinelli; Gianluca Civenni; Stéphanie Claudinot; Reinhard Dummer; Lisette Hari; Daniela Mihic-Probst; Holger Moch; Michal Okoniewski; Simon M Schaefer; Lukas Sommer
Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma.
Nature cell biology 2012;14(8):882-90.
2012: Peter J Wild; Rosmarie Caduff; Athanassios Dellas; Niklaus Fankhauser; Daniel Fink; Thomas J Fuchs; Strahil Georgiev; Kristian Ikenberg; Wilhelm Krek; Holger Moch; Aurelia Noske; Markus Rechsteiner; Matthias Roessle; Ian J Frew
p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans.
EMBO molecular medicine 2012;4(8):808-24.
2012: Peter Schraml; Bettina Seifert; Mathew Simcock; Reinhard Dummer; Olivier Michielin; Daniela Mihic-Probst; Holger Moch; Adrian Ochsenbein; Marc Schläppi; Adriana von Teichman; Roger von Moos
Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07.
Oncology reports 2012;28(2):654-8.
2012: Monika Julia Wolf; Adriano Aguzzi; Judith Bauer; Steffen Boettcher; Lubor Borsig; Roland S Croner; Alexandra Hoos; Markus Knust; Andreas Konrad; Matthias Lang; Markus G Manz; Holger Moch; Manolis Pasparakis; Marco Prinz; Christoph Schneider; Nicole Simonavicius; Michael Stürzl; Geert van Loo; Achim Weber; Mathias Heikenwalder
Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway.
Cancer cell 2012;22(1):91-105.
2012: Gunther Boysen; Igor Cima; Niklaus Fankhauser; Thomas Hermanns; Barbara Ingold-Heppner; Wilhelm Krek; Van-Duc Luu; Anna M Nowicka; Peter Schraml; Daniel Stiehl; Tullio Sulser; Claudio R Thoma; Adriana von Teichman; Roland H Wenger; Bernd Wollscheid; Damaris Bausch-Fluck; Holger Moch
Identification and functional characterization of pVHL-dependent cell surface proteins in renal cell carcinoma.
Neoplasia (New York, N.Y.) 2012;14(6):535-46.
2012: Matthias Dettmer; Paul Komminoth; Holger Moch; Anja Schmitt; Hans Steinert; Aurel Perren
Poorly differentiated oncocytic thyroid carcinoma--diagnostic implications and outcome.
Histopathology 2012;60(7):1045-51.
2012: Zsuzsanna Varga; Ursina Zuerrer-Hardi; Silvia Behnke; Glen Kristiansen; Cathy B Moelans; Constanze Ramach; Holger Moch
Topoisomerase 2A gene amplification in breast cancer. Critical evaluation of different FISH probes.
Breast cancer research and treatment 2012;133(3):929-35.
2012: Nicola L Schoenewolf; Peter Schraml; Mathew Simcock; Roger von Moos; Reinhard Dummer; Silke Gillessen; Daniela Mihic-Probst; Holger Moch; Adrian Ochsenbein
Detecting BRAF Mutations in Formalin-Fixed Melanoma: Experiences with Two State-of-the-Art Techniques.
Case reports in oncology 2012;5(2):280-9.
2012: Laura Morra; Markus Rechsteiner; Peter Schraml; Silvia Casagrande; Holger Moch; Adriana von Teichman; Alex Soltermann
Characterization of periostin isoform pattern in non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2012;76(2):183-90.
2012: Zsuzsanna Varga; Zhen Wang; Giovanna Bosshard; Wolfram Jochum; Doris Kradolfer; Holger Moch; Aurelia Noske; Yang Sun; Raymond R Tubbs; Christian Öhlschlegel
Co-amplification of the HER2 gene and chromosome 17 centromere: a potential diagnostic pitfall in HER2 testing in breast cancer.
Breast cancer research and treatment 2012;132(3):925-35.
2012: Carsten Denkert; Zsuzsanna Bago-Horvath; Kerstin Bohmann; Martin Filipits; Heinz Höfler; Dontscho Kerjaschki; Hans-Heinrich Kreipe; Ralf Kronenwett; Ulrich Lehmann; Holger Moch; Berit-Maria Müller; Roland Penzel; Christoph Petry; Judith Prinzler; Margaretha Rudas; Peter Schirmacher; Gudrun Schlake; Werner Schlake; Marcus Schmidt; Peter Schraml; Bruno Valentin Sinn; Katja Specht; Frank Tiecke; Zsuzsanna Varga; Karsten E Weber; Manfred Dietel
Decentral gene expression analysis for ER+/Her2- breast cancer: results of a proficiency testing program for the EndoPredict assay.
Virchows Archiv : an international journal of pathology 2012;460(3):251-9.
2012: Manfred Beleut; Nicole Bruni; Peter Bühlmann; Wilhelm Gruissem; Oliver Laule; Van-Duc Luu; Peter Schraml; Philip Zimmermann; Michael Baudis; Holger Moch
Integrative genome-wide expression profiling identifies three distinct molecular subgroups of renal cell carcinoma with different patient outcome.
BMC cancer 2012;12():310.
2012: Daniela Mihic-Probst; Holger Moch; Peter Schraml; Burkhardt Seifert; Lukas Sommer; Marianne Tinguely; Silvia Behnke; Gianluca Civenni; Kristian Ikenberg; Reinhard Dummer
Tumor cell plasticity and angiogenesis in human melanomas.
PloS one 2012;7(3):e33571.
2012: Holger Moch; J Palacios; F Penault-Llorca; G Rossi; P R Blank; Manfred Dietel; G Elmberger; K M Kerr; T D Szucs
Personalized cancer medicine and the future of pathology.
Virchows Archiv : an international journal of pathology 2012;460(1):3-8.
2011: Florian R Fritzsche; Anja Hasler; Heiner Adams; Andre Barghorn; Peter K Bode; Holger Moch; Hans H Seifert; Tullio Sulser; Glen Kristiansen
Expression of histone deacetylases 1, 2 and 3 in histological subtypes of testicular germ cell tumours.
Histology and histopathology 2011;26(12):1555-61.
2011: Stephan Schmid; Marianne Tinguely; P Cione; Holger Moch; B Bode
Flow cytometry as an accurate tool to complement fine needle aspiration cytology in the diagnosis of low grade malignant lymphomas.
Cytopathology : official journal of the British Society for Clinical Cytology 2011;22(6):397-406.
2011: Laura Morra; Holger Moch
Periostin expression and epithelial-mesenchymal transition in cancer: a review and an update.
Virchows Archiv : an international journal of pathology 2011;459(5):465-75.
2011: Holger Moch
[Documentation of the diagnostic quality of hospitals: evaluation of autopsy reports].
Der Pathologe 2011;32 Suppl 2():282-6.
2011: Gerhard F Huber; Holger Moch; Matthias Roessle; Alex Soltermann; Andrea Albinger-Hegyi; Nicole Graf; Stephan K Haerle; David Holzmann; Ivan Hegyi
Expression patterns of Bmi-1 and p16 significantly correlate with overall, disease-specific, and recurrence-free survival in oropharyngeal squamous cell carcinoma.
Cancer 2011;117(20):4659-70.
2011: Patricia Blank; Holger Moch; Thomas D Szucs; Klazien Matter-Walstra
KRAS and BRAF mutation analysis in metastatic colorectal cancer: a cost-effectiveness analysis from a Swiss perspective.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(19):6338-46.
2011: Patrick L Wagner; Walter Weder; Theresia Wilbertz; Nasser K Altorki; Falko Fend; Roopika Menon; Ralf Mikut; Holger Moch; Karen Petersen; Markus Reischl; Mark A Rubin; Veit Scheble; Alex Soltermann; Ann-Cathrin Stiedl; Sven Perner
Frequency and clinicopathologic correlates of KRAS amplification in non-small cell lung carcinoma.
Lung cancer (Amsterdam, Netherlands) 2011;74(1):118-23.
2011: Gerhard Frank Huber; Wolfram Jochum; Stephan K Haerle; Florian R Fritzsche; Nicole Graf; Sandro J Stoeckli; Monique Storz; Lena Züllig; Holger Moch
Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx.
International journal of cancer. Journal international du cancer 2011;129(6):1404-9.
2011: Daria Esterházy; Hans Hilpert; Julie Kerr Conte; Nora Lieske; Lorella Marselli; Hugues Matile; Cristiano Migliorini; Holger Moch; Michael Prummer; Markus P Rechsteiner; Alexander Schmidt; Giatgen Andreia Spinas; Ruedi Aebersold; Jeremy Beauchamp; Bernhard Boehm; Domenico Bosco; Heinz Döbeli; Ina Stützer; Haiyan Wang; Markus Stoffel
Bace2 is a β cell-enriched protease that regulates pancreatic β cell function and mass.
Cell metabolism 2011;14(3):365-77.
2011: Laura Morra; Markus Rechsteiner; Roger Santimaria; Peter Schraml; Silvia Casagrande; Pierre A Diener; Van Duc Luu; Glen Kristiansen; Holger Moch; Tullio Sulser; Alex Soltermann
Relevance of periostin splice variants in renal cell carcinoma.
The American journal of pathology 2011;179(3):1513-21.
2011: Markus P Rechsteiner; Peter Schraml; Tullio Sulser; Adriana von Teichman; Anna Nowicka; Holger Moch
VHL gene mutations and their effects on hypoxia inducible factor HIFα: identification of potential driver and passenger mutations.
Cancer research 2011;71(16):5500-11.
2011: Aurelia Noske; Zsuzsanna Varga; Anne-Katrin Zimmermann; Rosmarie Caduff; Daniel Fink; Holger Moch; Glen Kristiansen
Alpha-methylacyl-CoA racemase (AMACR) expression in epithelial ovarian cancer.
Virchows Archiv : an international journal of pathology 2011;459(1):91-7.
2011: Raphael Butsch; Dimitri Korol; Julia Braun; Stephan Lukas Waelti; Holger Moch; Nicole Probst-Hensch; Sarah Schaerer; Michael Kurrer
Intratumoral plasmacytoid dendritic cells associate with increased survival in patients with follicular lymphoma.
Leukemia & lymphoma 2011;52(7):1230-8.
2011: Peter K Bode; Florian R Fritzsche; Alexander Knuth; Glen Kristiansen; André Barghorn; Marc-Oliver Riener; Holger Moch
MAGEC2 is a sensitive and novel marker for seminoma: a tissue microarray analysis of 325 testicular germ cell tumors.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2011;24(6):829-35.
2011: Carsten T Viehl; Igor Langer; Ulrich Guller; Rosanna Zanetti-Dällenbach; Holger Moch; Edward Wight; Daniel Oertli; Markus Zuber
Prognostic impact and therapeutic implications of sentinel lymph node micro-metastases in early-stage breast cancer patients.
Journal of surgical oncology 2011;103(6):531-3.
2011: Gianluca Civenni; Anne Walter; Nikita Kobert; Daniela Mihic-Probst; Marie Zipser; Benedetta Belloni; Burkhardt Seifert; Holger Moch; Reinhard Dummer; Maries van den Broek; Lukas Sommer
Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth.
Cancer research 2011;71(8):3098-109.
2011: Adriana von Teichman; Eva Compérat; Silvia Behnke; Martina Storz; Holger Moch; Peter Schraml
VHL mutations and dysregulation of pVHL- and PTEN-controlled pathways in multilocular cystic renal cell carcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2011;24(4):571-8.
2011: Jean-Philippe Theurillat; Stefan Christian Metzler; Nico Henzi; Nabil Djouder; Marianne Helbling; Anna-Kathrin Zimmermann; Francis Jacob; Alex Soltermann; Rosmarie Caduff; Viola Heinzelmann-Schwarz; Holger Moch; Wilhelm Krek
URI is an oncogene amplified in ovarian cancer cells and is required for their survival.
Cancer cell 2011;19(3):317-32.
2011: Ashkan Mortezavi; Thomas Hermanns; Hans-Helge Seifert; Martin K Baumgartner; Maurizio Provenzano; Tullio Sulser; Maximilian Burger; Matteo Montani; Kristian Ikenberg; Ferdinand Hofstädter; Arndt Hartmann; Rolf Jaggi; Holger Moch; Glen Kristiansen; Peter J Wild
KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(5):1111-21.
2011: Stefanie Arbogast; Silvia Behnke; Isabelle Opitz; Rolf A Stahel; Burkhardt Seifert; Walter Weder; Holger Moch; Alex Soltermann
Automated ERCC1 immunohistochemistry in non-small cell lung cancer: comparison of anti-ERCC1 antibodies 8F1, D-10, and FL-297.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2011;19(2):99-105.
2011: Anu Sharma; Roland H Wenger; Lotta von Boehmer; Beata Bode; Alexander Knuth; Kuno Lehmann; Holger Moch; Alessandro A Sartori; Maries van den Broek
γ-Radiation promotes immunological recognition of cancer cells through increased expression of cancer-testis antigens in vitro and in vivo.
PloS one 2011;6(11):e28217.
2011: Verena Tischler; Walter Weder; Martin L Sos; Peter Altevogt; Anne-Katrine Bonde; Silke Hausladen; Glen Kristiansen; Holger Moch; Marco Pfeifer; Uwe Schirmer; Alex Soltermann
L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer.
Molecular cancer 2011;10():127.
2011: Alex Soltermann; Martina Storz; Silvia Behnke; Sandra Kilgus-Hawelski; Holger Moch; Beata Bode
Automated ERCC1 immunochemistry on hybrid cytology/tissue microarray of malignant effusions: evaluation of antibodies 8F1 and D-10.
Journal of clinical bioinformatics 2011;1():25.
2011: Przemyslaw Blyszczuk; Urs Eriksson; Davide Germano; Thomas F Lüscher; Christian M Matter; Holger Moch; Sokrates Stein; Beatrice Beck-Schimmer; Gabriela Kania
Profibrotic potential of prominin-1+ epithelial progenitor cells in pulmonary fibrosis.
Respiratory research 2011;12():126.
2011: Alessandra Curioni-Fontecedro; Reinhard Dummer; Alexander Knuth; Daniela Mihic-Probst; Natko Nuber; Burkhardt Seifert; Davide Soldini; Maries van den Broek; Holger Moch
Expression of MAGE-C1/CT7 and MAGE-C2/CT10 predicts lymph node metastasis in melanoma patients.
PloS one 2011;6(6):e21418.
2011: Gerhard F Huber; Wolfram Jochum; Holger Moch; Matthias Roessle; Alex Soltermann; Nicole Graf; Stephan K Haerle; Gabriela Studer; Lena Züllig; Sandro J Stoeckli
Down regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx.
BMC cancer 2011;11():217:1-8.
2010: Olivier Giger; Rosmarie Caduff; Alix O'Meara; Pierre-Andre Diener; Alexander Knuth; Dirk Jäger; Holger Moch; Zsuzsanna Varga
Frequent expression of the breast differentiation antigen NY-BR-1 in mammary and extramammary Paget's disease.
Pathology international 2010;60(11):726-34.
2010: Florian Rudolf Fritzsche; Tanja Reineke; Lars Morawietz; Glen Kristiansen; Manfred Dietel; Daniel Fink; Christoph Rageth; Christoph Honegger; Rosmarie Caduff; Holger Moch; Zsuzsanna Varga
Pathological processing techniques and final diagnosis of breast cancer sentinel lymph nodes.
Annals of surgical oncology 2010;17(11):2892-8.
2010: Patricia R Blank; Matthias Schwenkglenks; Holger Moch; Thomas D Szucs
Human epidermal growth factor receptor 2 expression in early breast cancer patients: a Swiss cost-effectiveness analysis of different predictive assay strategies.
Breast cancer research and treatment 2010;124(2):497-507.
2010: Holger Moch
[Cystic renal neoplasms. New entities and molecular findings].
Der Pathologe 2010;31 Suppl 2():239-43.
2010: Gladell P Paner; Mahul B Amin; Isabel Alvarado-Cabrero; Andrew N Young; Hans J Stricker; Holger Moch; Robert H Lyles
A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade.
The American journal of surgical pathology 2010;34(9):1233-40.
2010: Andreas M Studer; Ludwig K Limbach; Luu Van Duc; Frank Krumeich; Evagelos K Athanassiou; Lukas C Gerber; Holger Moch; Wendelin J Stark
Nanoparticle cytotoxicity depends on intracellular solubility: comparison of stabilized copper metal and degradable copper oxide nanoparticles.
Toxicology letters 2010;197(3):169-74.
2010: Jean-Philippe Theurillat; Birgit Dreier; Gabriela Nagy-Davidescu; Burkhardt Seifert; Silvia Behnke; Ursina Zürrer-Härdi; Fabienne Ingold; Andreas Plückthun; Holger Moch
Designed ankyrin repeat proteins: a novel tool for testing epidermal growth factor receptor 2 expression in breast cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2010;23(9):1289-97.
2010: Natko Nuber; Alessandra Curioni-Fontecedro; Claudia Matter; Davide Soldini; Jean-Marie Tiercy; Lotta von Boehmer; Holger Moch; Reinhard Dummer; Alexander Knuth; Maries van den Broek
Fine analysis of spontaneous MAGE-C1/CT7-specific immunity in melanoma patients.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(34):15187-92.
2010: Leah N Cueni; Ivan Hegyi; Jay W Shin; Andrea Albinger-Hegyi; Silke Gruber; Rainer Kunstfeld; Holger Moch; Michael Detmar
Tumor lymphangiogenesis and metastasis to lymph nodes induced by cancer cell expression of podoplanin.
The American journal of pathology 2010;177(2):1004-16.
2010: Anne Walter; Marjam J Barysch; Silvia Behnke; Piotr Dziunycz; Bruno Schmid; Erika Ritter; Sacha Gnjatic; Glen Kristiansen; Holger Moch; Alexander Knuth; Reinhard Dummer; Maries van den Broek
Cancer-testis antigens and immunosurveillance in human cutaneous squamous cell and basal cell carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(14):3562-70.
2010: Glen Kristiansen; M Rose; C Geisler; F R Fritzsche; J Gerhardt; C Lüke; A-M Ladhoff; R Knüchel; Manfred Dietel; Holger Moch; Zsuzsanna Varga; Jean-Philippe Theurillat; T A Gorr; Edgar Dahl
Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype.
British journal of cancer 2010;102(12):1736-45.
2010: Andrea Albinger-Hegyi; Sandro J Stoeckli; Stephan Schmid; Monique Storz; Guergana Iotzova; Nicole M Probst-Hensch; Hubert Rehrauer; Marianne Tinguely; Holger Moch; Ivan Hegyi
Lysyl oxidase expression is an independent marker of prognosis and a predictor of lymph node metastasis in oral and oropharyngeal squamous cell carcinoma (OSCC).
International journal of cancer. Journal international du cancer 2010;126(11):2653-62.
2010: Verena Tischler; Florian R Fritzsche; Josefine Gerhardt; Christian Jäger; Carsten Stephan; Klaus Jung; Manfred Dietel; Holger Moch; Glen Kristiansen
Comparison of the diagnostic value of fatty acid synthase (FASN) with alpha-methylacyl-CoA racemase (AMACR) as prostatic cancer tissue marker.
Histopathology 2010;56(6):811-5.
2010: Holger Moch
Cystic renal tumors: new entities and novel concepts.
Advances in anatomic pathology 2010;17(3):209-14.
2010: Marc-Oliver Riener; Florian R Fritzsche; Christopher Soll; Bernhard C Pestalozzi; Nicole M Probst-Hensch; Pierre-Alain Clavien; Wolfram Jochum; Alex Soltermann; Holger Moch; Glen Kristiansen
Expression of the extracellular matrix protein periostin in liver tumours and bile duct carcinomas.
Histopathology 2010;56(5):600-6.
2010: Alexandra Schramm; Isabelle Opitz; Svenja Thies; Burkhardt Seifert; Holger Moch; Walter Weder; Alex Soltermann
Prognostic significance of epithelial-mesenchymal transition in malignant pleural mesothelioma.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2010;37(3):566-72.
2010: Nicole M Probst-Hensch; Julia H B Steiner; Peter Schraml; Zsuzsanna Varga; Ursina Zürrer-Härdi; Martina Storz; Dimitri Korol; Mathias K Fehr; Daniel Fink; Bernhard C Pestalozzi; Urs M Lütolf; Jean-Philippe Theurillat; Holger Moch
IGFBP2 and IGFBP3 protein expressions in human breast cancer: association with hormonal factors and obesity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(3):1025-32.
2010: K Peter R Nilsson; Kristian Ikenberg; Andreas Aslund; Sophia Fransson; Peter Konradsson; Christoph Röcken; Holger Moch; Adriano Aguzzi
Structural typing of systemic amyloidoses by luminescent-conjugated polymer spectroscopy.
The American journal of pathology 2010;176(2):563-74.
2010: Mona Leuenberger; Simona Frigerio; Peter J Wild; Franziska Noetzli; Dimitri Korol; Dieter R Zimmermann; Carole Gengler; Nicole M Probst-Hensch; Holger Moch; Marianne Tinguely
AID protein expression in chronic lymphocytic leukemia/small lymphocytic lymphoma is associated with poor prognosis and complex genetic alterations.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2010;23(2):177-86.
2010: Kristian Ikenberg; Florian R Fritzsche; Ursina Zuerrer-Haerdi; Irina Hofmann; Thomas Hermanns; Helge Seifert; Michael Müntener; Maurizio Provenzano; Tullio Sulser; Silvia Behnke; Josefine Gerhardt; Ashkan Mortezavi; Peter Wild; Ferdinand Hofstädter; Maximilian Burger; Holger Moch; Glen Kristiansen
Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scores.
BMC cancer 2010;10():341.
2010: Verena Tischler; Florian R Fritzsche; Peter J Wild; Carsten Stephan; Hans-Helge Seifert; Marc-Oliver Riener; Thomas Hermanns; Ashkan Mortezavi; Josefine Gerhardt; Peter Schraml; Klaus Jung; Holger Moch; Alex Soltermann; Glen Kristiansen
Periostin is up-regulated in high grade and high stage prostate cancer.
BMC cancer 2010;10():273.
2010: Corinne Dahinden; Barbara Ingold; Peter Wild; Gunther Boysen; Van-Duc Luu; Matteo Montani; Glen Kristiansen; Tullio Sulser; Peter Bühlmann; Holger Moch; Peter Schraml
Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(1):88-98.
2009: G Boysen; Bernd Wollscheid; D Bausch-Fluck; P Schraml; Holger Moch
[Identification of VHL-associated changes in clear cell renal carcinoma: the application of combined genome and expression analyses].
Der Pathologe 2009;30 Suppl 2():188-92.
2009: Anja M Schmitt; Sonja Schmid; T Rudolph; Martin Anlauf; C Prinz; G Klöppel; Holger Moch; Philipp U Heitz; Paul Komminoth; Aurel Perren
VHL inactivation is an important pathway for the development of malignant sporadic pancreatic endocrine tumors.
Endocrine-related cancer 2009;16(4):1219-27.
2009: Holger Moch; Walter Artibani; Brett Delahunt; Vincenzo Ficarra; Ruth Knuechel; Francesco Montorsi; Jean-Jacques Patard; Christian G Stief; Tullio Sulser; Peter J Wild
Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma.
European urology 2009;56(4):636-43.
2009: Kuppusamy Balamurugan; V-D Luu; M R Kaufmann; V S Hofmann; G Boysen; Sandra Barth; M R Bordoli; Daniel Stiehl; Holger Moch; P Schraml; Roland H Wenger; Gieri Camenisch
Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response.
Oncogene 2009;28(37):3274-85.
2009: Claudio R Thoma; Alberto Toso; Katrin L Gutbrodt; Sabina P Reggi; Ian J Frew; Peter Schraml; Alexander Hergovich; Holger Moch; Patrick Meraldi; Wilhelm Krek
VHL loss causes spindle misorientation and chromosome instability.
Nature cell biology 2009;11(8):994-1001.
2009: Igor Langer; Ulrich Guller; S F Hsu-Schmitz; A Ladewig; Carsten T Viehl; Holger Moch; Edward Wight; Felix Harder; Daniel Oertli; Markus Zuber
Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2009;35(8):805-13.
2009: Peter J Wild; Thomas Fuchs; Robert Stoehr; Dieter R Zimmermann; Simona Frigerio; Barbara Padberg; Inbal Steiner; Ellen C Zwarthoff; Maximilian Burger; Stefan Denzinger; Ferdinand Hofstaedter; Glen Kristiansen; Thomas Hermanns; Hans-Helge Seifert; Maurizio Provenzano; Tullio Sulser; Volker Roth; Joachim M Buhmann; Holger Moch; Arndt Hartmann
Detection of urothelial bladder cancer cells in voided urine can be improved by a combination of cytology and standardized microsatellite analysis.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(6):1798-806.
2009: Van-Duc Luu; Gunther Boysen; Kirsten Struckmann; Silvia Casagrande; Adriana von Teichman; Peter J Wild; Tullio Sulser; Peter Schraml; Holger Moch
Loss of VHL and hypoxia provokes PAX2 up-regulation in clear cell renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(10):3297-304.
2009: Marc-Oliver Riener; Frank Stenner; Heike Liewen; Christopher Soll; Stefan Breitenstein; Bernhard C Pestalozzi; Panagiotis Samaras; Nicole M Probst-Hensch; Claus Hellerbrand; Beat Müllhaupt; Pierre-Alain Clavien; Marcus Bahra; Peter Neuhaus; Peter Wild; Florian Fritzsche; Holger Moch; Wolfram Jochum; Glen Kristiansen
Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas.
Hepatology (Baltimore, Md.) 2009;49(5):1602-9.
2009: Martin Anlauf; Juliane Bauersfeld; Andreas Raffel; Christian A Koch; Tobias Henopp; Ibrahim Alkatout; Anja Schmitt; Achim Weber; Marie-Luise Kruse; Stefan Braunstein; Klaus Kaserer; Michael Brauckhoff; Henning Dralle; Holger Moch; Philipp U Heitz; Paul Komminoth; Wolfram T Knoefel; Aurel Perren; Günter Klöppel
Insulinomatosis: a multicentric insulinoma disease that frequently causes early recurrent hyperinsulinemic hypoglycemia.
The American journal of surgical pathology 2009;33(3):339-46.
2009: Xenofon Floros; Thomas Fuchs; Markus P Rechsteiner; Giatgen Spinas; Holger Moch; Joachim M Buhmann
Graph-based pancreatic islet segmentation for early type 2 diabetes mellitus on histopathological tissue.
Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention 2009;12(Pt 2):633-40.
2009: Barbara Ingold; Peter Schraml; Frank L Heppner; Holger Moch
Homogeneous MGMT immunoreactivity correlates with an unmethylated MGMT promoter status in brain metastases of various solid tumors.
PloS one 2009;4(3):e4775.
2009: Florian R Fritzsche; Glen Kristiansen; Thomas Frauenfelder; Isabelle Opitz; Peter Bode; Holger Moch; matteo montani
Large mixed germ cell tumor in a young patient presenting as an intrapulmonary mass.
Pathology, research and practice 2009;205(8):572-8.
2009: Peter Schraml; Ian J Frew; Claudio R Thoma; Gunther Boysen; Kirsten Struckmann; Wilhelm Krek; Holger Moch
Sporadic clear cell renal cell carcinoma but not the papillary type is characterized by severely reduced frequency of primary cilia.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009;22(1):31-6.
2009: Igor Langer; Ulrich Guller; Gilles Berclaz; Ossi R Koechli; Holger Moch; Gabriel Schaer; Mathias K Fehr; Thomas Hess; Daniel Oertli; Lucio Bronz; Beate Schnarwyler; Edward Wight; Urs Uehlinger; Eduard Infanger; Daniel Burger; Markus Zuber
Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study.
Breast cancer research and treatment 2009;113(1):129-36.
2008: Donat R Spahn; Holger Moch; Axel Hofmann; James P Isbister
Patient blood management: the pragmatic solution for the problems with blood transfusions.
Anesthesiology 2008;109(6):951-3.
2008: Mahul B Amin; Gladell P Paner; Isabel Alvarado-Cabrero; Andrew N Young; Hans J Stricker; Robert H Lyles; Holger Moch
Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases.
The American journal of surgical pathology 2008;32(12):1822-34.
2008: Alex Soltermann; Verena Tischler; Stefanie Arbogast; Julia Braun; Nicole Probst-Hensch; Walter Weder; Holger Moch; Glen Kristiansen
Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(22):7430-7.
2008: Florian R Fritzsche; Beibei Oelrich; Manfred Johannsen; Ilka Kristiansen; Holger Moch; Klaus Jung; Glen Kristiansen
Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(21):7035-42.
2008: Marianne Tinguely; A Hofmann; D Bausch-Fluck; Holger Moch; B Wollscheid
Immunophenotyping without antibodies. New perspectives for lymphoma characterization.
Der Pathologe 2008;29 Suppl 2():314-6.
2008: V D Luu; B Fischer; A von Teichman; G Boysen; Kirsten D Mertz; Philip Zimmermann; Holger Moch; P Schraml
[Von-Hippel-Lindau gene mutation types. Association of gene expression signatures in clear cell renal cell carcinoma].
Der Pathologe 2008;29 Suppl 2():303-7.
2008: Markus Reschke; Daniela Mihic-Probst; Edward van der Horst; Pjotr Knyazev; Peter J Wild; Markus Hutterer; Stefanie Meyer; Reinhard Dummer; Holger Moch; Axel Ullrich
HER3 is a determinant for poor prognosis in melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(16):5188-97.
2008: Kirsten D Mertz; Francesca Demichelis; Andrea Sboner; Michelle S Hirsch; Paola Dal Cin; Kirsten Struckmann; Martina Storz; Simone Scherrer; Daniel M Schmid; Räto T Strebel; Nicole M Probst-Hensch; Mark Gerstein; Holger Moch; Mark A Rubin
Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer.
International journal of cancer. Journal international du cancer 2008;123(3):569-76.
2008: Ian J Frew; Andrea Minola; Strahil Georgiev; Manuela Hitz; Holger Moch; Stéphane Richard; Alexander O Vortmeyer; Wilhelm Krek
Combined VHLH and PTEN mutation causes genital tract cystadenoma and squamous metaplasia.
Molecular and cellular biology 2008;28(14):4536-48.
2008: Ian J Frew; Claudio R Thoma; Strahil Georgiev; Andrea Minola; Manuela Hitz; matteo montani; Holger Moch; Wilhelm Krek
pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation.
The EMBO journal 2008;27(12):1747-57.
2008: B Ingold; P J Wild; A Nocito; Mahul B Amin; M Storz; F L Heppner; Holger Moch
Renal cell carcinoma marker reliably discriminates central nervous system haemangioblastoma from brain metastases of renal cell carcinoma.
Histopathology 2008;52(6):674-81.
2008: Alex Soltermann; Reto Ossola; Sandra Kilgus-Hawelski; Arnold von Eckardstein; Tobias Suter; Ruedi Aebersold; Holger Moch
N-glycoprotein profiling of lung adenocarcinoma pleural effusions by shotgun proteomics.
Cancer 2008;114(2):124-33.
2008: Robert Waibel; Hansjörg Treichler; Niklaus G Schaefer; Dave R van Staveren; Stefan Mundwiler; Susanne Kunze; Martin Küenzi; Roger Alberto; Jakob Nüesch; Alexander Knuth; Holger Moch; Roger Schibli; P August Schubiger
New derivatives of vitamin B12 show preferential targeting of tumors.
Cancer research 2008;68(8):2904-11.
2008: Z Varga; C Rageth; E Saurenmann; C Honegger; S von Orelli; Mathias K Fehr; D Fink; B Seifert; Holger Moch; RF Caduff
Use of intraoperative stereomicroscopy for preventing loss of metastases during frozen sectioning of sentinel lymph nodes in breast cancer.
Histopathology 2008;52(5):597-604.
2008: Marianne Tinguely; Bettina Jenni; Ashley Knights; B Lopes; D Korol; V Rousson; A Curioni Fontecedro; Sergio B Cogliatti; Anne Greet Bittermann; U Schmid; Corina Dommann-Scherrer; Robert Maurer; C Renner; Nicole M Probst-Hensch; Holger Moch; Alexander Knuth; A Zippelius
MAGE-C1/CT-7 expression in plasma cell myeloma: sub-cellular localization impacts on clinical outcome.
Cancer science 2008;99(4):720-5.
2008: Jean-Philippe Theurillat; Ursina Zürrer-Härdi; Zsuzsanna Varga; André Barghorn; Elisabeth Saller; Claudia Frei; Martina Storz; Silvia Behnke; Burkhardt Seifert; Mathias K Fehr; Daniel Fink; Christoph Rageth; Claudia Linsenmeier; Bernhard Pestalozzi; Yao-Tseng Chen; Alexander Knuth; Dirk Jäger; Holger Moch
Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts.
International journal of cancer. Journal international du cancer 2008;122(7):1585-91.
2008: Sven Perner; Patrick L Wagner; Francesca Demichelis; Rohit Mehra; Christopher J Lafargue; Benjamin J Moss; Stefanie Arbogast; Alex Soltermann; Walter Weder; Thomas J Giordano; David G Beer; David S Rickman; Arul M Chinnaiyan; Holger Moch; Mark A Rubin
EML4-ALK fusion lung cancer: a rare acquired event.
Neoplasia (New York, N.Y.) 2008;10(3):298-302.
2008: Nele Garbrecht; Martin Anlauf; Anja Schmitt; Tobias Henopp; Bence Sipos; Andreas Raffel; Claus F Eisenberger; Wolfram T Knoefel; Marianne Pavel; Christian Fottner; Thomas J Musholt; Anja Rinke; Rudolf Arnold; Uta Berndt; Ursula Plöckinger; Bertram Wiedenmann; Holger Moch; Philipp U Heitz; Paul Komminoth; Aurel Perren; Günter Klöppel
Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity.
Endocrine-related cancer 2008;15(1):229-41.
2008: Anja M Schmitt; Florian Riniker; Martin Anlauf; Sonja Schmid; Alex Soltermann; Holger Moch; Philipp U Heitz; Günther Klöppel; Paul Komminoth; Aurel Perren
Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases.
The American journal of surgical pathology 2008;32(3):420-5.
2008: Susanne Steu; Maya Baucamp; Gabriela von Dach; Marion Bawohl; Susanne Dettwiler; Martina Storz; Holger Moch; Peter Schraml
A procedure for tissue freezing and processing applicable to both intra-operative frozen section diagnosis and tissue banking in surgical pathology.
Virchows Archiv : an international journal of pathology 2008;452(3):305-12.
2008: Isabelle Opitz; Alex Soltermann; Martin Abaecherli; Marc Hinterberger; Nicole Probst-Hensch; Rolf Stahel; Holger Moch; Walter Weder
PTEN expression is a strong predictor of survival in mesothelioma patients.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2008;33(3):502-6.
2008: Mohammad Vasei; Holger Moch; Abdollah Mousavi; Abdol-Mohammad Kajbafzadeh; Guido Sauter
Immunohistochemical profiling of Wilms tumor: a tissue microarray study.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2008;16(2):128-34.
2008: Kirsten Struckmann; Kirsten D Mertz; S Steu; Martina Storz; P Staller; Wilhelm Krek; Peter Schraml; Holger Moch
pVHL co-ordinately regulates CXCR4/CXCL12 and MMP2/MMP9 expression in human clear-cell renal cell carcinoma.
The Journal of pathology 2008;214(4):464-71.
2008: Achim Weber; Ilka Kristiansen; Manfred Johannsen; Beibei Oelrich; Katharina Scholmann; Sven Gunia; Matthias May; Hellmuth-Alexander Meyer; Silvia Behnke; Holger Moch; Glen Kristiansen
The FUSE binding proteins FBP1 and FBP3 are potential c-myc regulators in renal, but not in prostate and bladder cancer.
BMC cancer 2008;8():369.
2008: Thomas Fuchs; Peter J Wild; Holger Moch; Joachim M Buhmann
Computational pathology analysis of tissue microarrays predicts survival of renal clear cell carcinoma patients.
Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention 2008;11(Pt 2):1-8.
2008: Jianming Zhao; Holger Moch
Absence of JH2 domain mutation of the tyrosine kinase JAK2 in renal cell carcinomas.
Acta oncologica (Stockholm, Sweden) 2008;47(3):474-6.
2007: Elisabeth Bruder; Holger Moch; David Ehrlich; Ivo Leuschner; Dieter Harms; Pedram Argani; Jakob Briner; Norbert Graf; Barbara Selle; Alex Rufle; Michael Paulussen; Robert Koesters
Wnt signaling pathway analysis in renal cell carcinoma in young patients.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007;20(12):1217-29.
2007: Anja M Schmitt; Martin Anlauf; Valentin Rousson; Sonja Schmid; Andreas Kofler; Florian Riniker; Juliane Bauersfeld; Andre Barghorn; Nicole M Probst-Hensch; Holger Moch; Philipp U Heitz; Guenter Kloeppel; Paul Komminoth; Aurel Perren
WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors.
The American journal of surgical pathology 2007;31(11):1677-82.
2007: Beata Bode-Lesniewska; Simona Frigerio; U Exner; Marie-Therese Abdou; Holger Moch; Dieter R Zimmermann
Relevance of translocation type in myxoid liposarcoma and identification of a novel EWSR1-DDIT3 fusion.
Genes, chromosomes & cancer 2007;46(11):961-71.
2007: Jean-Philippe Theurillat; Ursina Zürrer-Härdi; Zsuzsanna Varga; Martina Storz; Nicole M Probst-Hensch; Burkhardt Seifert; Mathias K Fehr; Daniel Fink; Soldano Ferrone; Bernhard C Pestalozzi; Achim A Jungbluth; Yao-Tseng Chen; Dirk Jäger; Alexander Knuth; Holger Moch
NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapy.
Cancer immunology, immunotherapy : CII 2007;56(11):1723-31.
2007: Daniela Mihic-Probst; Ariana Kuster; Sandra Kilgus; Beata Bode-Lesniewska; Barbara Ingold-Heppner; Carly Leung; Martina Storz; Burkhardt Seifert; Silvia Marino; Peter Schraml; Reinhard Dummer; Holger Moch
Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma.
International journal of cancer. Journal international du cancer 2007;121(8):1764-70.
2007: Kirsten D Mertz; Francesca Demichelis; Robert Kim; Peter Schraml; Martina Storz; Pierre-André Diener; Holger Moch; Mark A Rubin
Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancer.
Human pathology 2007;38(10):1454-62.
2007: Simona Frigerio; Barbara C Padberg; Raeto T Strebel; Daniela M Lenggenhager; Angelika Messthaler; Marie-Therese Abdou; Holger Moch; Dieter R Zimmermann
Improved detection of bladder carcinoma cells in voided urine by standardized microsatellite analysis.
International journal of cancer. Journal international du cancer 2007;121(2):329-38.
2007: Sylvia Stadlmann; Uwe Gueth; Daniel Baumhoer; Holger Moch; Luigi Terracciano; Gad Singer
Glypican-3 expression in primary and recurrent ovarian carcinomas.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2007;26(3):341-4.
2007: Simone Schmid; Milos Opravil; Michael Moddel; Milo Huber; Rahel Pfammatter; Gerald Keusch; Patrice Ambuhl; Rudolf P Wuthrich; Holger Moch; Zsuzsanna Varga
Acute interstitial nephritis of HIV-positive patients under atazanavir and tenofovir therapy in a retrospective analysis of kidney biopsies.
Virchows Archiv : an international journal of pathology 2007;450(6):665-70.
2007: Jean-Philippe Theurillat; Fabienne Ingold; Claudia Frei; Alfred Zippelius; Zsuzsanna Varga; Burkhardt Seifert; Yao-Tseng Chen; Dirk Jäger; Alexander Knuth; Holger Moch
NY-ESO-1 protein expression in primary breast carcinoma and metastases: correlation with CD8+ T-cell and CD79a+ plasmacytic/B-cell infiltration.
International journal of cancer. Journal international du cancer 2007;120(11):2411-7.
2007: J Zhao; Armelle Yart; S Frigerio; Aurel Perren; Peter Schraml; C Weisstanner; T Stallmach; Wilhelm Krek; Holger Moch
Sporadic human renal tumors display frequent allelic imbalances and novel mutations of the HRPT2 gene.
Oncogene 2007;26(23):3440-9.
2007: Marianne Tinguely; Bettina Jenni; Tanja Reineke; Dimitri Korol; Andreas Kofler; Valentin Rousson; Corina Dommann-Scherrer; Robert Maurer; Holger Moch; Nicole M Probst-Hensch
Chromosomal translocations t(4;14), t(11;14) and proliferation rate stratify patients with mature plasma cell myelomas into groups with different survival probabilities: a molecular epidemiologic study on tissue microarrays.
The American journal of surgical pathology 2007;31(5):690-6.
2007: Lars C Huber; Matthias Brock; Hossein Hemmatazad; Olivier T Giger; Falk Moritz; Michelle Trenkmann; Jörg H W Distler; Renate E Gay; Christoph Kolling; Holger Moch; Beat A Michel; Steffen Gay; Oliver Distler; Astrid Jüngel
Histone deacetylase/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients.
Arthritis and rheumatism 2007;56(4):1087-93.
2007: Olivier T Giger; Elena Lacoste; Christoph Honegger; Barbara Padberg; Holger Moch; Zsuzsanna Varga
Expression of the breast differentiation antigen NY-BR-1 in a phyllodes tumor of the vulva.
Virchows Archiv : an international journal of pathology 2007;450(4):471-4.
2007: Michela Ceschi; Felix Gutzwiller; Holger Moch; Monika Eichholzer; Nicole M Probst-Hensch
Epidemiology and pathophysiology of obesity as cause of cancer.
Swiss medical weekly 2007;137(3-4):50-6.
2007: Z Varga; C Rageth; E Saurenmann; C Honegger; S von Orelli; M Fehr; D Fink; B Seifert; Holger Moch; R Caduff
[Loss of metastatic deposits in breast sentinel lymph nodes during intra-operative frozen section analysis].
Verhandlungen der Deutschen Gesellschaft für Pathologie 2007;91():221-4.
2006: Aurel Perren; Peter Wiesli; Sonja Schmid; matteo montani; Anja Schmitt; Christoph Schmid; Holger Moch; Paul Komminoth
Pancreatic endocrine tumors are a rare manifestation of the neurofibromatosis type 1 phenotype: molecular analysis of a malignant insulinoma in a NF-1 patient.
The American journal of surgical pathology 2006;30(8):1047-51.
2006: Tanja Reineke; Bettina Jenni; Marie-Therese Abdou; Simona Frigerio; Petra Zubler; Holger Moch; Marianne Tinguely
Ultrasonic decalcification offers new perspectives for rapid FISH, DNA, and RT-PCR analysis in bone marrow trephines.
The American journal of surgical pathology 2006;30(7):892-6.
2006: Zsuzsanna Varga; Jean-Philippe Theurillat; Valeriy Filonenko; Bernd Sasse; Bernhard Odermatt; Achim A Jungbluth; Yao-Tseng Chen; Lloyd J Old; Alexander Knuth; Dirk Jäger; Holger Moch
Preferential nuclear and cytoplasmic NY-BR-1 protein expression in primary breast cancer and lymph node metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(9):2745-51.
2006: Daniela Mihic-Probst; Christian Mnich; Patrick A Oberholzer; Burkhardt Seifert; Bernd Sasse; Holger Moch; Reinhard Dummer
p16 expression in primary malignant melanoma is associated with prognosis and lymph node status.
International journal of cancer. Journal international du cancer 2006;118(9):2262-8.
2006: Beata Bode; Simona Frigerio; Silvia Behnke; Belinda Senn; Bernhard Odermatt; Dieter R Zimmermann; Holger Moch
Mutations in the tyrosine kinase domain of the EGFR gene are rare in synovial sarcoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(4):541-7.
2006: Kirsten D Mertz; Joëlle Tchinda; R Küfer; P Möller; Mark A Rubin; Holger Moch; Sven Perner
[Cytogenetic alterations in renal tumors. Applications for comparative genomic hybridization and fluorescence in situ hybridization].
Der Urologe. Ausg. A 2006;45(3):316-8, 320-2.
2005: Walter P Weber; Rosanna Zanetti; Igor Langer; Sophie Dellas; Markus Zuber; Holger Moch; Eugenia Remmel; Daniel Oertli; Edward Wight; Walter R Marti
Mammotome: less invasive than ABBI with similar accuracy for early breast cancer detection.
World journal of surgery 2005;29(4):495-9.
2005: Kirsten Struckmann; Kirsten D Mertz; P Staller; Wilhelm Krek; Peter Schraml; Holger Moch
[mRNA expression analysis of metastatic markers in clear-cell renal cell carcinoma].
Verhandlungen der Deutschen Gesellschaft für Pathologie 2005;89():178-83.
2005: Igor Langer; Walter R Marti; Ulrich Guller; Holger Moch; Felix Harder; Daniel Oertli; Markus Zuber
Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy.
Annals of surgery 2005;241(1):152-8.
2005: Philip Thomas Went; Stephan Dirnhofer; Tiziana Salvisberg; Mahul B Amin; So D Lim; Pierre-André Diener; Holger Moch
Expression of epithelial cell adhesion molecule (EpCam) in renal epithelial tumors.
The American journal of surgical pathology 2005;29(1):83-8.
2004: Gad Singer; Thore Kallinowski; Arndt Hartmann; Wolfgang Dietmaier; Peter J Wild; Peter Schraml; Guido Sauter; Michael J Mihatsch; Holger Moch
Different types of microsatellite instability in ovarian carcinoma.
International journal of cancer. Journal international du cancer 2004;112(4):643-6.
2004: Elisabeth Bruder; Oliver Passera; Dieter Harms; Ivo Leuschner; Marc Ladanyi; Pedram Argani; John N Eble; Kirsten Struckmann; Peter Schraml; Holger Moch
Morphologic and molecular characterization of renal cell carcinoma in children and young adults.
The American journal of surgical pathology 2004;28(9):1117-32.
2004: Elisabeth Bruder; Holger Moch
[Pediatric renal cell carcinoma].
Der Pathologe 2004;25(4):324-7.
2004: Luigi Tornillo; Holger Moch; Pierre-André Diener; Alessandro Lugli; Gad Singer
CDX-2 immunostaining in primary and secondary ovarian carcinomas.
Journal of clinical pathology 2004;57(6):641-3.
2004: Kirsten Struckmann; Peter Schraml; Ronald Simon; Katja Elmenhorst; Martina Mirlacher; Juha Kononen; Holger Moch
Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma.
Cancer research 2004;64(5):1632-8.
2004: Holger Moch
Genomic alterations in renal tumours: what have we learned in the era of comparative genomic hybridisation?
Pathology 2004;36(1):51-7.
2004: Athanassios Dellas; Alex Puhl; Peter Schraml; Sabine E Thomke; Josef Rüschoff; Michael J Mihatsch; Holger Moch
Molecular and clinicopathological analysis of ovarian carcinomas with and without microsatellite instability.
Anticancer research 2004;24(1):361-9.
2003: Holger Moch; A Wodzynski; L Guillou; Volker Nickeleit
[Primary renal synovial sarcoma. A new entity in the morphological spectrum of spindle cell renal tumors].
Der Pathologe 2003;24(6):466-72.
2003: A Weber; J Srigley; Holger Moch
[Mucinous spindle cell carcinoma of the kidney. A molecular analysis].
Der Pathologe 2003;24(6):453-9.
2003: Luigi Terracciano; Barbara Bernasconi; Peter Ruck; Thomas Stallmach; Jakob Briner; Guido Sauter; Holger Moch; Raffaella Vecchione; Lucio Pollice; Guido Pettinato; Barbara Gürtl; Manfred Ratschek; Ronald R de Krijger; Luigi Tornillo; Elisabeth Bruder
Comparative genomic hybridization analysis of hepatoblastoma reveals high frequency of X-chromosome gains and similarities between epithelial and stromal components.
Human pathology 2003;34(9):864-71.
2003: Peter Schraml; Alexander Hergovich; Florian Hatz; Mahul B Amin; So D Lim; Wilhelm Krek; Michael J Mihatsch; Holger Moch; Alexander Hergovitz
Relevance of nuclear and cytoplasmic von hippel lindau protein expression for renal carcinoma progression.
The American journal of pathology 2003;163(3):1013-20.
2003: Peter Schraml; Georg Schwerdtfeger; Felix Burkhalter; Anna Raggi; Dietmar Schmidt; Teresa Ruffalo; Walter King; Kim Wilber; Michael J Mihatsch; Holger Moch
Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma.
The American journal of pathology 2003;163(3):985-92.
2003: Athanassios Dellas; Joachim Torhorst; Reto Gaudenz; Michael J Mihatsch; Holger Moch
DNA copy number changes in cervical adenocarcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(8):2985-91.
2003: Ulrich Guller; Egbert Nitzsche; Holger Moch; Markus Zuber
Is positron emission tomography an accurate non-invasive alternative to sentinel lymph node biopsy in breast cancer patients?
Journal of the National Cancer Institute 2003;95(14):1040-3.
2002: Holger Moch; Michael J Mihatsch
Genetic progression of renal cell carcinoma.
Virchows Archiv : an international journal of pathology 2002;441(4):320-7.
2002: Alessandro Lugli; F Stoffe; Luigi Terracciano; Stephan Dirnhofer; Michael J Mihatsch; Holger Moch
[Differentiated papillary kidney tumors. Differentiation between metanephric adenoma and papillary adenoma].
Der Pathologe 2002;23(4):303-7.
2002: Athanassios Dellas; Joachim Torhorst; Elisabeth Schultheiss; Michael J Mihatsch; Holger Moch
DNA sequence losses on chromosomes 11p and 18q are associated with clinical outcome in lymph node-negative ductal breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(5):1210-6.
2002: Luigi Tornillo; Vincenza Carafa; Guido Sauter; Holger Moch; Ernesto Minola; Marcello Gambacorta; Raffaella Vecchione; Leonardo Bianchi; Luigi Terracciano
Chromosomal alterations in hepatocellular nodules by comparative genomic hybridization: high-grade dysplastic nodules represent early stages of hepatocellular carcinoma.
Laboratory investigation; a journal of technical methods and pathology 2002;82(5):547-53.
2002: Ronald Simon; Kirsten Struckmann; Peter Schraml; Urs Wagner; Thomas Forster; Holger Moch; André Fijan; James Bruderer; Kim Wilber; Michael J Mihatsch; Thomas Gasser; Guido Sauter
Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer.
Oncogene 2002;21(16):2476-83.
2002: Peter Schraml; Kirsten Struckmann; Florian Hatz; Stefan Sonnet; Charlotte Kully; Thomas Gasser; Guido Sauter; Michael J Mihatsch; Holger Moch
VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma.
The Journal of pathology 2002;196(2):186-93.
2002: Holger Moch
[Renal tumors in adults: rare tumors and new tumor entities].
Verhandlungen der Deutschen Gesellschaft für Pathologie 2002;86():40-8.
2002: Ulrich Guller; Egbert Nitzsche; Udo Schirp; Carsten T Viehl; Joachim Torhorst; Holger Moch; Igor Langer; Walter R Marti; Daniel Oertli; Felix Harder; Markus Zuber
Selective axillary surgery in breast cancer patients based on positron emission tomography with 18F-fluoro-2-deoxy-D-glucose: not yet!
Breast cancer research and treatment 2002;71(2):171-3.
2001: Jianming Zhao; Holger Moch; Alexander Scheidweiler; A Baer; A A Schäffer; Ernst J M Speel; Jürgen Roth; Philipp U Heitz; Paul Komminoth
Genomic imbalances in the progression of endocrine pancreatic tumors.
Genes, chromosomes & cancer 2001;32(4):364-72.
2001: Joachim Torhorst; christoph bucher; Juha Kononen; Philippe Haas; Markus Zuber; Ossi R Köchli; Frank Mross; Holger Dieterich; Holger Moch; Michael J Mihatsch; Olli Kallioniemi; Guido Sauter
Tissue microarrays for rapid linking of molecular changes to clinical endpoints.
The American journal of pathology 2001;159(6):2249-56.
2001: Lukas Bubendorf; Antonio Nocito; Holger Moch; Guido Sauter
Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies.
The Journal of pathology 2001;195(1):72-9.
2001: Ronald Simon; Antonio Nocito; T Hübscher; christoph bucher; Joachim Torhorst; Peter Schraml; Lukas Bubendorf; M M Mihatsch; Holger Moch; Kim Wilber; A Schötzau; Juha Kononen; Guido Sauter
Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer.
Journal of the National Cancer Institute 2001;93(15):1141-6.
2001: Antonio Nocito; Lukas Bubendorf; E M Tinner; K Süess; Urs Wagner; Thomas Forster; Juha Kononen; André Fijan; James Bruderer; Ulrico Schmid; Daniel Ackermann; Robert Maurer; Göran Alund; Hartmut Knönagel; Marcus Rist; M Anabitarte; Franz Hering; T Hardmeier; A J Schoenenberger; Renata Flury; Peter Jäger; Jean Luc Fehr; Peter Schraml; Holger Moch; Michael J Mihatsch; Thomas Gasser; Guido Sauter
Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade.
The Journal of pathology 2001;194(3):349-57.
2001: Ronald Simon; J Richter; Urs Wagner; André Fijan; James Bruderer; Ulrico Schmid; Daniel Ackermann; Robert Maurer; Göran Alund; Hartmut Knönagel; Marcus Rist; Kim Wilber; M Anabitarte; Franz Hering; T Hardmeier; Andreas Schönenberger; Renata Flury; Peter Jäger; Jean Luc Fehr; Peter Schraml; Holger Moch; Michael J Mihatsch; Thomas Gasser; Guido Sauter
High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer.
Cancer research 2001;61(11):4514-9.
2001: S Tomovska; J Richter; K Süess; Urs Wagner; E Rozenblum; Thomas C Gasser; Holger Moch; Michael J Mihatsch; Guido Sauter; Peter Schraml
Molecular cytogenetic alterations associated with rapid tumor cell proliferation in advanced urinary bladder cancer.
International journal of oncology 2001;18(6):1239-44.
2001: Roberto Casella; Holger Moch; C Rochlitz; V Meier; B Seifert; Michael J Mihatsch; Thomas C Gasser
Metastatic primitive neuroectodermal tumor of the kidney in adults.
European urology 2001;39(5):613-7.
2001: A El Gedaily; Lukas Bubendorf; Niels Willi; W Fu; J Richter; Holger Moch; Michael J Mihatsch; Guido Sauter; Thomas C Gasser
Discovery of new DNA amplification loci in prostate cancer by comparative genomic hybridization.
The Prostate 2001;46(3):184-90.
2001: Peter Schraml; Kirsten Struckmann; R Bednar; W Fu; Thomas Gasser; Kim Wilber; Juha Kononen; Guido Sauter; Michael J Mihatsch; Holger Moch
CDKNA2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas: evidence for a second tumor suppressor gene proximal to CDKN2A.
The American journal of pathology 2001;158(2):593-601.
2000: Feng Jiang; Richard Desper; CH Papadimitriou; A A Schäffer; Olli Kallioniemi; J Richter; Peter Schraml; Guido Sauter; Michael J Mihatsch; Holger Moch
Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridization data.
Cancer research 2000;60(22):6503-9.
2000: W Fu; Lukas Bubendorf; Niels Willi; Holger Moch; Michael J Mihatsch; Guido Sauter; Thomas C Gasser
Genetic changes in clinically organ-confined prostate cancer by comparative genomic hybridization.
Urology 2000;56(5):880-5.
2000: Luigi Tornillo; Vincenza Carafa; J Richter; Guido Sauter; Holger Moch; Ernesto Minola; Marcello Gambacorta; Leonardo Bianchi; Raffaella Vecchione; Luigi Terracciano
Marked genetic similarities between hepatitis B virus-positive and hepatitis C virus-positive hepatocellular carcinomas.
The Journal of pathology 2000;192(3):307-12.
2000: J Richter; Urs Wagner; Juha Kononen; André Fijan; James Bruderer; Ulrico Schmid; Daniel Ackermann; Robert Maurer; Göran Alund; Hartmut Knönagel; Marcus Rist; Kim Wilber; M Anabitarte; Franz Hering; T Hardmeier; Andreas Schönenberger; Renata Flury; Peter Jäger; Jean Luc Fehr; Peter Schraml; Holger Moch; Michael J Mihatsch; Thomas Gasser; Olli Kallioniemi; Guido Sauter
High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer.
The American journal of pathology 2000;157(3):787-94.
2000: Lukas Bubendorf; A Schöpfer; Urs Wagner; Guido Sauter; Holger Moch; Niels Willi; Thomas C Gasser; Michael J Mihatsch
Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients.
Human pathology 2000;31(5):578-83.
2000: Peter Schraml; D Müller; R Bednar; Thomas Gasser; Guido Sauter; Michael J Mihatsch; Holger Moch
Allelic loss at the D9S171 locus on chromosome 9p13 is associated with progression of papillary renal cell carcinoma.
The Journal of pathology 2000;190(4):457-61.
2000: Richard Desper; F Jiang; Olli Kallioniemi; Holger Moch; CH Papadimitriou; Alejandro A Schäffer
Distance-based reconstruction of tree models for oncogenesis.
Journal of computational biology : a journal of computational molecular cell biology 2000;7(6):789-803.
1999: Ernst J M Speel; J Richter; Holger Moch; C Egenter; Parvin Saremaslani; K Rütimann; Jianming Zhao; Andre Barghorn; Jürgen Roth; Philipp U Heitz; Paul Komminoth
Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization.
The American journal of pathology 1999;155(6):1787-94.
1999: J Richter; Urs Wagner; Peter Schraml; Robert Maurer; Göran Alund; Hartmut Knönagel; Holger Moch; Michael J Mihatsch; Thomas C Gasser; Guido Sauter
Chromosomal imbalances are associated with a high risk of progression in early invasive (pT1) urinary bladder cancer.
Cancer research 1999;59(22):5687-91.
1999: Lukas Bubendorf; M Kolmer; Juha Kononen; Pasi A Koivisto; Spyro Mousses; Yidong Chen; Eija H Mahlamäki; Peter Schraml; Holger Moch; Niels Willi; Abdel G Elkahloun; T G Pretlow; Thomas C Gasser; Michael J Mihatsch; Guido Sauter; Olli Kallioniemi
Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays.
Journal of the National Cancer Institute 1999;91(20):1758-64.
1999: Luigi Terracciano; J Richter; Luigi Tornillo; L Beffa; Pierre-André Diener; Robert Maurer; Thomas C Gasser; Holger Moch; Michael J Mihatsch; Guido Sauter
Chromosomal imbalances in small cell carcinomas of the urinary bladder.
The Journal of pathology 1999;189(2):230-5.
1999: J Zhao; J Richter; Urs Wagner; B Roth; Peter Schraml; Tobias Zellweger; Daniel Ackermann; Ulrico Schmid; Holger Moch; Michael J Mihatsch; Thomas C Gasser; Guido Sauter
Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa).
Cancer research 1999;59(18):4658-61.
1999: Peter Schraml; Juha Kononen; Lukas Bubendorf; Holger Moch; Heidi Bissig; Antonio Nocito; Michael J Mihatsch; Olli Kallioniemi; Guido Sauter
Tissue microarrays for gene amplification surveys in many different tumor types.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(8):1966-75.
1999: Athanassios Dellas; Joachim Torhorst; Feng Jiang; J Proffitt; Elisabeth Schultheiss; Wolfgang Holzgreve; Guido Sauter; Michael J Mihatsch; Holger Moch
Prognostic value of genomic alterations in invasive cervical squamous cell carcinoma of clinical stage IB detected by comparative genomic hybridization.
Cancer research 1999;59(14):3475-9.
1999: Heidi Bissig; J Richter; Richard Desper; V Meier; Peter Schraml; A A Schäffer; Guido Sauter; Michael J Mihatsch; Holger Moch
Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization.
The American journal of pathology 1999;155(1):267-74.
1999: Urs Wagner; K Süess; T Luginbühl; Ulrico Schmid; Daniel Ackermann; Tobias Zellweger; Robert Maurer; Göran Alund; Hartmut Knönagel; Marcus Rist; P Jordan; Holger Moch; Michael J Mihatsch; Thomas C Gasser; Guido Sauter
Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer.
The Journal of pathology 1999;188(1):44-50.
1999: Holger Moch; Peter Schraml; Lukas Bubendorf; Martina Mirlacher; Juha Kononen; Thomas Gasser; Michael J Mihatsch; Olli Kallioniemi; Guido Sauter
High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma.
The American journal of pathology 1999;154(4):981-6.
1999: Lukas Bubendorf; Juha Kononen; Pasi A Koivisto; Peter Schraml; Holger Moch; Thomas C Gasser; Niels Willi; Michael J Mihatsch; Guido Sauter; Olli Kallioniemi
Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays.
Cancer research 1999;59(4):803-6.
1999: Holger Moch; Peter Schraml; Lukas Bubendorf; Martina Mirlacher; Juha Kononen; Thomas Gasser; Michael J Mihatsch; Olli Kallioniemi; Guido Sauter
[Identification of prognostic parameters for renal cell carcinoma by cDNA arrays and cell chips].
Verhandlungen der Deutschen Gesellschaft für Pathologie 1999;83():225-32.
1999: Peter Schraml; M Zhaou; J Richter; T Brüning; M Pommer; Guido Sauter; Michael J Mihatsch; Holger Moch
[Analysis of kidney tumors in trichloroethylene exposed workers by comparative genomic hybridization and DNA sequence analysis].
Verhandlungen der Deutschen Gesellschaft für Pathologie 1999;83():218-24.
1999: Richard Desper; Feng Jiang; Olli Kallioniemi; Holger Moch; CH Papadimitriou; Alejandro A Schäffer
Inferring tree models for oncogenesis from comparative genome hybridization data.
Journal of computational biology : a journal of computational molecular cell biology 1999;6(1):37-51.
1999: M Neuhaus; Urs Wagner; Ulrico Schmid; Daniel Ackermann; Tobias Zellweger; Robert Maurer; Göran Alund; Hartmut Knönagel; Marcus Rist; Holger Moch; Michael J Mihatsch; Thomas C Gasser; Guido Sauter
Polysomies but not Y chromosome losses have prognostic significance in pTa/pT1 urinary bladder cancer.
Human pathology 1999;30(1):81-6.
1998: Athanassios Dellas; Elisabeth Schultheiss; M R Leivas; Holger Moch; Joachim Torhorst
Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms.
Anticancer research 1998;18(6A):3991-8.
1998: Holger Moch; O M Braun; Luigi Terracciano; Michael J Mihatsch
[Epithelioid angiomyolipoma of the kidney--a new tumor entity. Case report on a tumor with many multinucleated giant cells].
Der Pathologe 1998;19(6):436-41.
1998: J Richter; L Beffa; Urs Wagner; Peter Schraml; Thomas C Gasser; Holger Moch; Michael J Mihatsch; Guido Sauter
Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization.
The American journal of pathology 1998;153(5):1615-21.
1998: Feng Jiang; J Richter; Peter Schraml; Lukas Bubendorf; Thomas Gasser; Guido Sauter; Michael J Mihatsch; Holger Moch
Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes.
The American journal of pathology 1998;153(5):1467-73.
1998: Lukas Bubendorf; Coya Tapia; Thomas C Gasser; Roberto Casella; B Grunder; Holger Moch; Michael J Mihatsch; Guido Sauter
Ki67 labeling index in core needle biopsies independently predicts tumor-specific survival in prostate cancer.
Human pathology 1998;29(9):949-54.
1998: Feng Jiang; Holger Moch; J Richter; C Egenter; Thomas Gasser; Lukas Bubendorf; R Gschwind; Guido Sauter; Michael J Mihatsch
Comparative genomic hybridization reveals frequent chromosome 13q and 4q losses in renal carcinomas with sarcomatoid transformation.
The Journal of pathology 1998;185(4):382-8.
1998: Roberto Casella; Lukas Bubendorf; Guido Sauter; Holger Moch; Michael J Mihatsch; Thomas C Gasser
Focal neuroendocrine differentiation lacks prognostic significance in prostate core needle biopsies.
The Journal of urology 1998;160(2):406-10.
1998: Holger Moch; Peter Schraml; Lukas Bubendorf; J Richter; Thomas C Gasser; Michael J Mihatsch; Guido Sauter
Intratumoral heterogeneity of von Hippel-Lindau gene deletions in renal cell carcinoma detected by fluorescence in situ hybridization.
Cancer research 1998;58(11):2304-9.
1998: Holger Moch; Guido Sauter; Thomas C Gasser; Lukas Bubendorf; J Richter; J C Presti; F M Waldman; Michael J Mihatsch
EGF-r gene copy number changes in renal cell carcinoma detected by fluorescence in situ hybridization.
The Journal of pathology 1998;184(4):424-9.
1998: K Süess; Holger Moch; R Epper; A Koller; Ursula Dürmüller; Michael J Mihatsch
[Heterogeneity of seminal vesicle amyloid. Immunohistochemical detection of lactoferrin and amyloid of the prealbumin-transthyretin type].
Der Pathologe 1998;19(2):115-9.
1998: Guido Sauter; Holger Moch; Michael J Mihatsch; T C Gasser
Molecular cytogenetics of bladder cancer progression.
European urology 1998;33 Suppl 4():9-10.
1998: Guido Sauter; Lukas Bubendorf; Holger Moch; Thomas C Gasser; Michael J Mihatsch
[Cytogenetic changes in prostatic carcinoma].
Der Pathologe 1998;19(1):63-8.
1997: Holger Moch; Guido Sauter; N Buchholz; Thomas C Gasser; Lukas Bubendorf; F M Waldman; Michael J Mihatsch
Epidermal growth factor receptor expression is associated with rapid tumor cell proliferation in renal cell carcinoma.
Human pathology 1997;28(11):1255-9.
1997: Athanassios Dellas; Holger Moch; Elisabeth Schultheiss; Georg Feichter; AC Almendral; Fred Gudat; Joachim Torhorst
Angiogenesis in cervical neoplasia: microvessel quantitation in precancerous lesions and invasive carcinomas with clinicopathological correlations.
Gynecologic oncology 1997;67(1):27-33.
1997: Peter Dalquen; Holger Moch; Georg Feichter; M Lehmann; Markus Solèr; Peter Stulz; P Jordan; Joachim Torhorst; Michael J Mihatsch; Guido Sauter
DNA aneuploidy, S-phase fraction, nuclear p53 positivity, and survival in non-small-cell lung carcinoma.
Virchows Archiv : an international journal of pathology 1997;431(3):173-9.
1997: Urs Wagner; Lukas Bubendorf; Thomas C Gasser; Holger Moch; J P Görög; J Richter; Michael J Mihatsch; F M Waldman; Guido Sauter
Chromosome 8p deletions are associated with invasive tumor growth in urinary bladder cancer.
The American journal of pathology 1997;151(3):753-9.
1997: Athanassios Dellas; Elisabeth Schultheiss; AC Almendral; Fred Gudat; Martin Oberholzer; Georg Feichter; Holger Moch; Joachim Torhorst
Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia.
International journal of cancer. Journal international du cancer 1997;74(4):421-5.
1997: J Richter; Feng Jiang; J P Görög; G Sartorius; C Egenter; Thomas C Gasser; Holger Moch; Michael J Mihatsch; Guido Sauter
Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization.
Cancer research 1997;57(14):2860-4.
1997: Guido Sauter; Holger Moch; U Wagner; Lukas Bubendorf; Thomas C Gasser; M J Mihatsch
[Genomic changes in urinary bladder cancer].
Verhandlungen der Deutschen Gesellschaft für Pathologie 1997;81():287-96.
1997: Guido Sauter; Thomas C Gasser; Holger Moch; J Richter; Feng Jiang; R Albrecht; Hedvika Novotny; Urs Wagner; Lukas Bubendorf; Michael J Mihatsch
DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH.
Urological research 1997;25 Suppl 1():S37-43.
1997: Holger Moch; Guido Sauter; Thomas C Gasser; N Buchholz; Lukas Bubendorf; J Richter; Feng Jiang; Athanassios Dellas; Michael J Mihatsch
p53 protein expression but not mdm-2 protein expression is associated with rapid tumor cell proliferation and prognosis in renal cell carcinoma.
Urological research 1997;25 Suppl 1():S25-30.
1996: Joseph C Presti; Holger Moch; Victor E Reuter; D Huynh; Frederic M Waldman
Comparative genomic hybridization for genetic analysis of renal oncocytomas.
Genes, chromosomes & cancer 1996;17(4):199-204.
1996: Joseph C Presti; Holger Moch; Victor E Reuter; C Cordon-Cardo; Frederic M Waldman
Renal cell carcinoma genetic analysis by comparative genomic hybridization and restriction fragment length polymorphism analysis.
The Journal of urology 1996;156(1):281-5.
1996: Lukas Bubendorf; Guido Sauter; Holger Moch; P Jordan; A Blöchlinger; Thomas C Gasser; M J Mihatsch
Prognostic significance of Bcl-2 in clinically localized prostate cancer.
The American journal of pathology 1996;148(5):1557-65.
1996: Lukas Bubendorf; Guido Sauter; Holger Moch; H P Schmid; Thomas C Gasser; P Jordan; Michael J Mihatsch
Ki67 labelling index: an independent predictor of progression in prostate cancer treated by radical prostatectomy.
The Journal of pathology 1996;178(4):437-41.
1996: Guido Sauter; Georg Feichter; Joachim Torhorst; Holger Moch; H Novotna; Urs Wagner; Ursula Dürmüller; Frederic M Waldman
Fluorescence in situ hybridization for detecting erbB-2 amplification in breast tumor fine needle aspiration biopsies.
Acta cytologica 1996;40(2):164-73.
1996: Holger Moch; J C Presti; Guido Sauter; N Buchholz; P Jordan; Michael J Mihatsch; Frederic M Waldman
Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma.
Cancer research 1996;56(1):27-30.
1995: Guido Sauter; Holger Moch; Thomas C Gasser; Michael J Mihatsch; Frederic M Waldman
Heterogeneity of chromosome 17 and erbB-2 gene copy number in primary and metastatic bladder cancer.
Cytometry 1995;21(1):40-6.
1995: Urs Wagner; Guido Sauter; Holger Moch; H Novotna; R Epper; Michael J Mihatsch; Frederic M Waldman
Patterns of p53, erbB-2, and EGF-r expression in premalignant lesions of the urinary bladder.
Human pathology 1995;26(9):970-8.
1995: Guido Sauter; Holger Moch; Urs Wagner; H Novotna; Thomas C Gasser; G Mattarelli; Michael J Mihatsch; Frederic M Waldman
Y chromosome loss detected by FISH in bladder cancer.
Cancer genetics and cytogenetics 1995;82(2):163-9.
1995: Guido Sauter; P Carroll; Holger Moch; Anne Kallioniemi; RL Kerschmann; P Narayan; Michael J Mihatsch; Frederic M Waldman
c-myc copy number gains in bladder cancer detected by fluorescence in situ hybridization.
The American journal of pathology 1995;146(5):1131-9.
1995: Guido Sauter; Holger Moch; P Carroll; RL Kerschmann; Michael J Mihatsch; Frederic M Waldman
Chromosome-9 loss detected by fluorescence in situ hybridization in bladder cancer.
International journal of cancer. Journal international du cancer 1995;64(2):99-103.
1995: N P Buchholz; Holger Moch; T C Gasser; R P Linke; G T Thiel; Michael J Mihatsch
Ureteral amyloid deposits of beta 2-microglobulin origin in both kidney recipients of 1 donor.
The Journal of urology 1995;153(2):399-401.
1994: Holger Moch; Guido Sauter; Michael J Mihatsch; Fred Gudat; R Epper; Frederic M Waldman
p53 but not erbB-2 expression is associated with rapid tumor proliferation in urinary bladder cancer.
Human pathology 1994;25(12):1346-51.
1994: Guido Sauter; J Haley; Karen L Chew; RL Kerschmann; D Moore; P Carroll; Holger Moch; Fred Gudat; Michael J Mihatsch; Frederic M Waldman
Epidermal-growth-factor-receptor expression is associated with rapid tumor proliferation in bladder cancer.
International journal of cancer. Journal international du cancer 1994;57(4):508-14.
1994: Guido Sauter; G Deng; Holger Moch; RL Kerschmann; K Matsumura; S De Vries; T George; J Fuentes; P Carroll; Michael J Mihatsch
Physical deletion of the p53 gene in bladder cancer. Detection by fluorescence in situ hybridization.
The American journal of pathology 1994;144(4):756-66.
1994: Holger Moch; H Ohnacker; R Epper; Fred Gudat; Michael J Mihatsch
A new case of malignant mesothelioma of the tunica vaginalis testis. Immunohistochemistry in comparison with an adenomatoid tumor of the testis.
Pathology, research and practice 1994;190(4):400-4; discussion 404-8.
1994: Holger Moch; M Spöndlin; A Schmassmann; Michael J Mihatsch
[Systemic karyomegaly with chronic interstitial nephritis. Discussion of the disease picture based on an autopsy case].
Der Pathologe 1994;15(1):44-8.
1994: N P Buchholz; Holger Moch; Michael J Mihatsch
Late urinary bladder metastases after radical resection of prostatic carcinoma.
Urologia internationalis 1994;53(1):50-2.
1994: N P Buchholz; Holger Moch; G E Feichter; H P Schmid; Michael J Mihatsch
Clinical and pathological features of highly malignant prostatic carcinomas with metastases to the penis.
Urologia internationalis 1994;53(3):135-8.
1993: Holger Moch; Joachim Torhorst; Ursula Dürmüller; Georg Feichter; Guido Sauter; Fred Gudat
Comparative analysis of the expression of tenascin and established prognostic factors in human breast cancer.
Pathology, research and practice 1993;189(5):510-4.
1993: Guido Sauter; Holger Moch; D Moore; P Carroll; RL Kerschmann; Karen L Chew; Michael J Mihatsch; Fred Gudat; Frederic M Waldman
Heterogeneity of erbB-2 gene amplification in bladder cancer.
Cancer research 1993;53(10 Suppl):2199-203.
1993: Holger Moch; Martin Oberholzer; H Christen; M Buser; Peter Dalquen; W Wegmann; Fred Gudat
Diagnostic tools for differentiating pleural mesothelioma from lung adenocarcinoma in paraffin embedded tissue. II. Design of an expert system and its application to the diagnosis of mesothelioma.
Virchows Archiv. A, Pathological anatomy and histopathology 1993;423(6):493-6.
1993: Holger Moch; Martin Oberholzer; Peter Dalquen; W Wegmann; Fred Gudat
Diagnostic tools for differentiating between pleural mesothelioma and lung adenocarcinoma in paraffin embedded tissue. Part I: Immunohistochemical findings.
Virchows Archiv. A, Pathological anatomy and histopathology 1993;423(1):19-27.
1993: Holger Moch; S Kiener; Peter Dalquen; Fred Gudat
[Pseudomesotheliomatous adenocarcinoma of the lung. Immunohistochemical study with special reference to detection of blood group isoantigens and Ber-EP4 antigen].
Der Pathologe 1993;14(1):11-5.
1993: Guido Sauter; Holger Moch; Fred Gudat; Michael J Mihatsch; J Haley; T Meecker; Frederic M Waldman
[Demonstration of gene amplification in urinary bladder cancer by fluorescent in situ hybridization (FISH)].
Verhandlungen der Deutschen Gesellschaft für Pathologie 1993;77():247-51.
1993: Holger Moch; Guido Sauter; Fred Gudat; Frederic M Waldman; Michael J Mihatsch
[Ki-67 fraction, p53 alteration and numerical chromosome aberrations (chromosomes 7 and 17) in formalin fixed bladder tumors].
Verhandlungen der Deutschen Gesellschaft für Pathologie 1993;77():226-30.
1993: Holger Moch; Guido Sauter; D Moore; Michael J Mihatsch; Fred Gudat; Frederic M Waldman
p53 and erbB-2 protein overexpression are associated with early invasion and metastasis in bladder cancer.
Virchows Archiv. A, Pathological anatomy and histopathology 1993;423(5):329-34.